Hasil Pencarian - Ghulam Rehman Mohyuddin

Perbaiki Hasil
  1. 1
    Primary Myelofibrosis Presenting as Extramedullary Hematopoiesis in a Transplanted Liver Graft: Case Report and Review of the Literature

    Primary Myelofibrosis Presenting as Extramedullary Hematopoiesis in a Transplanted Liver Graft: Case Report and Review of the Literature oleh Ghulam Rehman Mohyuddin, Abdulraheem Yacoub

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    A Rare Cause of Hemophagocytic Lymphohistiocytosis: Fusobacterium Infection—A Case Report and Review of the Literature

    A Rare Cause of Hemophagocytic Lymphohistiocytosis: Fusobacterium Infection—A Case Report and Review of the Literature oleh Ghulam Rehman Mohyuddin, Heather J. Male

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    A Rare Presentation of a Rare Disease: Pulmonary Lymphomatoid Granulomatosis

    A Rare Presentation of a Rare Disease: Pulmonary Lymphomatoid Granulomatosis oleh Ghulam Rehman Mohyuddin, Fatima Sultan, Ghulam Khaleeq

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    : Acute acquired demyelinating polyneuropathy – an initial presentation of diffuse large B cell lymphoma

    : Acute acquired demyelinating polyneuropathy – an initial presentation of diffuse large B cell lymphoma oleh Munira Shabbir- Moosajee, Ghulam Rehman Mohyuddin, Sara Khan, Ayeesha Kamal

    Diterbitkan 2014-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Acute Acquired Demyelinating Polyneuropathy:An Initial Presentation of Diffuse Large B Cell Lymphoma

    Acute Acquired Demyelinating Polyneuropathy:An Initial Presentation of Diffuse Large B Cell Lymphoma oleh Munira Shabbir-Moosajee, Ghulam Rehman Mohyuddin, Sara Khan, Ayeesha Kamran Kamal

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Clinician preferences on treatment of smoldering myeloma: a cross-sectional surveyResearch in context

    Clinician preferences on treatment of smoldering myeloma: a cross-sectional surveyResearch in context oleh Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Edward R. Scheffer Cliff, Benjamin A. Derman

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Hospitalization at the end of life in patients with multiple myeloma

    Hospitalization at the end of life in patients with multiple myeloma oleh Saqib Abbasi, John Roller, Al-Ola Abdallah, Leyla Shune, Brian McClune, Douglas Sborov, Ghulam Rehman Mohyuddin

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Impact of age on treatment utilization for newly diagnosed multiple myeloma: a nationwide retrospective cohort study

    Impact of age on treatment utilization for newly diagnosed multiple myeloma: a nationwide retrospective cohort study oleh Ghulam Rehman Mohyuddin, Hira Mian, Anastasia Gayowsky, Hsien Seow, Rajshekhar Chakraborty, Gregory R. Pond, Samer Al Hadidi, Alissa Visram

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review

    Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review oleh Ghulam Rehman Mohyuddin, Muhammad Aziz, Alec Britt, Lee Wade, Weijing Sun, Joaquina Baranda, Raed Al-Rajabi, Anwaar Saeed, Anup Kasi

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease

    Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease oleh Al‐Ola Abdallah, Ghulam Rehman Mohyuddin, Nausheen Ahmed, Meera Mohan, Wei Cui, Leyla Shune, Zahra Mahmoudjafari, Joseph McGuirk, Siddhartha Ganguly, Shebli Atrash

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Performance of newer myeloma staging systems in a contemporary, large patient cohort

    Performance of newer myeloma staging systems in a contemporary, large patient cohort oleh Ghulam Rehman Mohyuddin, Samuel M. Rubinstein, Shaji Kumar, S. Vincent Rajkumar, Rafael Fonseca, Nadine H. Abdallah, Gregory S. Calip, Xiaoyan Wang, Christina M. Parrinello, Douglas Sborov

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    P1518: INFECTIONS FOLLOWING BISPECIFIC ANTIBODIES IN MYELOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS

    P1518: INFECTIONS FOLLOWING BISPECIFIC ANTIBODIES IN MYELOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS oleh Gemma Reynolds, Edward R Scheffer Cliff, Ghulam Rehman Mohyuddin, Rakesh Popat, Sholani Midha, Melissa Ng Liet Hing, Simon Harrison, Aaron Kesselheim, Benjamin W Teh

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study

    Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study oleh Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina Schinke, Anita D’Souza, Meera Mohan

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies

    Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies oleh Raleigh Ayoolu Fatoki, Kelly Koehn, Amar Kelkar, Samer Al Hadidi, Nikita Mehra, Hira Mian, Ola Landgren, Dickran Kazandjian, James Hoffman, Douglas W. Sborov, Ghulam Rehman Mohyuddin

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma

    Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma oleh Kellen Gil, Saqib Abbasi, Kathan Mehta, Brian McClune, Douglas Sborov, Nausheen Ahmed, Al-Ola Abdallah, Siddhartha Ganguly, Joseph McGuirk, Leyla Shune, Ghulam Rehman Mohyuddin

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015–2020

    Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015–2020 oleh Oliver Van Oekelen, Nicole Birrer, William Wesson, Vincent L. Galate, Edward R. Scheffer Cliff, Aaron M. Goodman, Al-Ola Abdallah, Rajshekhar Chakraborty, Vinay Prasad, Ghulam Rehman Mohyuddin

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Financial toxicity in hematological malignancies: a systematic review

    Financial toxicity in hematological malignancies: a systematic review oleh Evguenia Ouchveridze, Rahul Banerjee, Aakash Desai, Muhammad Aziz, Wade Lee-Smith, Hira Mian, Katherine Berger, Brian McClune, Douglas Sborov, Muzaffar Qazilbash, Shaji Kumar, Ghulam Rehman Mohyuddin

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy

    Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy oleh Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory S. Calip, Mustafa S. Ascha, Xiaoliang Wang, Samuel M. Rubinstein, Sascha Tuchman, Luciano Costa, Benjamin Haaland, Smith Giri, Hira Mian, Rafael Fonseca, Douglas Sborov

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review

    Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review oleh Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira Mian, Luciano J. Costa, Douglas Sborov, Ghulam Rehman Mohyuddin

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study

    Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study oleh Arleigh McCurdy, Hsien Seow, Gregory P. Pond, Anastasia Gayowsky, Rajshekhar Chakraborty, Alissa Visram, Rayan Kaedbey, Anita D’Souza, Ghulam Rehman Mohyuddin, Tanya M. Wildes, Rafael Fonseca, Hira Mian

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: